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The use of complex endovascular repairs to treat aneurysms
involving the visceral vessels has increased in popularity in
the last 10 years. A variety of methods of branch vessel
incorporation have been described that can be broadly
characterized as fusing of devices (i.e., branched or fenes-
trated repairs) or layering of devices (i.e., chimney or
sandwich repairs [chimneys, periscopes, snorkels
{CHIMPS}]). In the following sections, we will analyze the
literature evaluating fenestrated, branched, and CHIMPS
repairs. We have separated the analysis of juxtarenal (JAA)
and pararenal (PAA) aortic aneurysms from the analysis of
thoracoabdominal aortic aneurysms (TAAA), as the clinicalheterogeneity between these two groups is too great for
comparison.
PAA AND JAA
The chimney technique was ﬁrst described in 2003 by
Greenberg et al.,1 and was intended as a technique to raise
the sealing zone while ensuring renal artery patency in
patients with “short neck” infrarenal aneurysms when no
other options were available. It was later proposed by
Hiramoto et al. as a rescue procedure after accidental renal
coverage during endovascular aneurysm repair (EVAR).2
Since its original description, this technique has widely
spread as an option for JAA and PAA endovascular repairs,
in situations where fenestrated EVAR (FEVAR) would cause
552 Trans-Atlantic Debateunacceptable cost or manufacturing delays. It has also been
claimed that chimney graft EVAR (Ch-EVAR) could be used
in patients deemed unsuitable for F-EVAR, especially where
tortuous aortic anatomy is present.3Evidence for Ch-EVAR
Many case reports and small series reporting single-center
experiences with Ch-EVAR have been published. The most
relevant are listed in Table 1.2e11 While most of them agree
that Ch-EVAR is technically feasible, they also stress that these
procedures can be technically challenging, particularly in
emergency settings performed by inexperienced operators.
The best published evidence for Ch-EVAR comes in the
form of two meta-analyses that report early outcomes. The
ﬁrst, published in 2011 by Moulakakis et al.,12 evaluated the
outcomes of 93 patients from 15 studies. Among those
patients, 24.7% of procedures were performed in an
emergency setting for symptomatic or ruptured aneurysms.
A total of 134 chimney grafts were analyzed. Technical
success, deﬁned by the authors as completion of the
chimney procedure, was reported in all cases. However,
several studies included in this meta-analysis reported
persistent type I endoleaks at the end of the procedure (13/
93 patients; 14.0%),2,5,6 target vessel occlusions (3/134
vessels; 2.2%),5,6 and perioperative deaths (1/93 patients;
1.1%).6 Taking these outcomes into consideration, with a
more accepted deﬁnition of technical success,13 the out-
comes for the chimney procedure are less favorable. The
incidence of type I endoleak during early follow-up was
10.8% (10/93). Four were treated during a secondary
intervention, while six were considered as “low-ﬂow”
endoleaks and managed without intervention. EarlyTable 1. Early results of chimney graft endovascular aneurysm repair
Reference n Target
vessels (n)
Emergency
cases (n)
Technical
success (n)a
Typ
I
Ohrlander
et al. (2008)3
6 11 5 6/6 d
Hiramoto
et al. (2009)2
29 31 d 29/29 3
Donas
et al. (2010)4
15 15 5 15/15 d
Bruen
et al. (2011)5
21 37 d 20/21 1
Coscas
et al. (2011)6
16 26 4 14/16 2
Lee et al.
(2012)7
28 57 d 56/57 NR
Schiro et al.
(2013)8
9 9 2 9/9 2
Lachat et al.
(2013)9
77 169 NR 53/77 19
Ducasse
et al. (2014)10
22 22 d 21/22 1
Scali et al. (2014)11 41 76 8 38/41 1
Note. UK ¼ unknown; NR ¼ not reported.
a As deﬁned by reporting standards.13mortality was 4.3% (4/93), associated with one acute
mesenteric ischemia after superior mesenteric artery (SMA)
stenting, two patients with hemorrhagic shock secondary to
retroperitoneal hematoma, and one myocardial infarction.
After a mean follow-up of 9 months, target vessel patency
was 97.8% (131/134; occlusion of two renal and one SMA
stents).
In 2013, another meta-analysis, which evaluated 234
patients from 24 studies, was published by Wilson et al.14
This study reported results from JAA, thoracic aneurysms,
and TAAA repairs. Among the 176 patients treated for JAA,
postoperative target vessels patency was 98.7%. Type I
endoleaks were diagnosed in 13 patients (7.4%) at the end
of the procedure, and in 18 patients in total (10.2%) on the
postoperative computed tomography. The 30-day mortality
rate was 3.4%. These authors did not report technical suc-
cess. The 6-month patency rate was 97.7% (three more
chimneys had occluded).
Midterm outcomes with Ch-EVAR have also been published
and are summarized in Table 2. Recently Usai et al. published a
review of seven studies evaluating chimney patency.15 At a
mean follow-up of 14.4months, a 4.5% chimney occlusion rate
was reported (15/334). The mean time from procedure to
chimney graft occlusion was 3.5 months.
In the meta-analysis published by Wilson et al.,14 after a
mean follow-up of 12.1 months, two patients still had
persistent type I endoleaks, although of the 13 initially
diagnosed only ﬁve had been treated. Three more patients
required secondary interventions for late type I endoleaks
depicted during follow-up, and one for a type III endoleak.
Thirteen other undifferentiated type II or III endoleaks were
reported; all were managed conservatively. During follow-(juxtarenal aortic aneurysm/suprarenal aortic aneurysm).
e of endoleak Primary branch
patency
Early
re-
intervention
30-d
mortalityII III UK
d d d 11/11 None 0/6
8 d d 31/31 None 1/29
1 d d 15/15 None 0/15
d d d 36/37 NR 1/21
d d 1 25/26 5/16 2/16
NR NR NR 56/57 None 2/28
d d d 9/9 None 0/9
14 1 d 165/170a NR NR
(at least 2/77)
4 d d 22/22 1/22 1/22
d d d 76/76 2/41 2/41
Table 2. Mid-term outcomes of chimney graft endovascular aneurysm repair (suprarenal aortic aneurysma/juxtarenal aortic aneurysm).
Reference n Target
vessels
(n)
Mean follow-up,
mo (range)
Type of endoleak Primary
branch
patency
Re-intervention Chronic
dialysis
Aneurysm-
related
deatha
I II III UK
Follow-up < 12 mo
Ohrlander
et al. (2008)3
6 11 NR (0e24.0) d d d d 10/11 d 1/6 1/6
Hiramoto
et al. (2009)2
29 31 12.5 (0e74.7) d NR NR NR 31/31 One renal
additional stenting
for stenosis (9 mo)
0/29 1/29
Bruen
et al. (2011)5
21 37 NR d 1 d d One SMA
occlusion
One SMA
stenosis
Repeated
angioplasties
0/21 1/21
Coscas
et al. (2011)6
16 26 10.5 (2.0e19.0) 1 d d 1 25/26 25/26 0/14 2/16
Donas
et al. (2012)8
72 127 12.1 (1.0e26.0)
e15.9 (1.0
e29.0)
1 6 d d One left renal
occlusion (J45)
One renal
stenosis
One iliorenal bypass
Repeated renal
angioplasties
One proximal cuff
for persistent type
Ia endoleak
0% 0%
Lee et al.
(2012)6
28 57 10.7 (3.0e25.0) 2 3 1 d 56/57 One extender
cuff for treatment
of type III endoleak
1/28 2/28
Schiro
et al. (2013)8
9 9 12.0 (5.0e24.0) 2 d d d 9/9 None 0/9 2/9
Follow-up > 12 mo
Lachat
et al. (2013)9
77 169 25.5  16.0b 3 Type I/III 165/170 12/77 NR NR
Ducasse
et al. (2014)10
22 22 18 (7e35) d 3 d d 22/22 None 0/22 1/22
Scali
et al. (2014)11
41 76 18.2
(1.4e41.5)c
3 4 d 3 76/76 3/41 2/41 NR
Note. UK ¼ unknown; NR ¼ not reported; SMA ¼ superior mesenteric artery.
a Including 30-d mortality.
b Mean  SD.
c Median.
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months (patency rate 97.7%), but clinical outcomes were
not reported. Eight patients died during follow-up, all from
nonaneurysm-related causes, which represented a global
mortality of 11.4%. As the authors acknowledge, this study
represents a small sample size when compared with the
recent FEVAR meta-analysis, and is comprised of small se-
ries or case reports, which suggests early operator experi-
ence. The generalizability of these results is therefore
limited. Only three studies reported results over 12 months
(Table 2). The ﬁrst, published by Ducasse et al.,10 included
22 patients, with a mean follow-up of 18 months (range 7e
35 months). The second was published in 2013 by Lachat
et al.9 The authors report their experience in 77 patients
with a mean follow-up of 25 months (range 1e121
months). Technical success was 99% (only one renal artery
with early occlusion), but 20 patients (26.0%) were dis-
charged with a type I/III endoleak. A secondary procedure
for chimney-related complications was performed in 13
patients (17.0%). At the end of follow-up, three patients still
had a persistent type I/III endoleak. The overall mortalityrate was not clearly stated in their article. The third study
was published by Scali et al.11 It included 41 patients with a
median follow-up length of 18.2 months. Despite promising
early outcomes, the authors raised concerns regarding the
mid- and long-term rates of major adverse events (including
stent thrombosis and re-intervention) and recommended
restricting CHIMPS to patients who cannot beneﬁt from
another treatment. In 2015, a meta-analysis published by Li
et al. pooled 12 studies (236 patients, 355 chimneys).16 The
mean follow-up length was 12 months. The type I endoleak
and mortality rates during follow-up were 11.8% and 13.0%,
respectively.
Evidence for FEVAR
There is growing evidence for FEVAR emerging in the
literature: two meta-analyses evaluating FEVAR results have
included 660 and 629 patients, respectively. The ﬁrst was
published in 2012 by Cross et al.17 The 30-day pooled
proportion mortality was 2.0% (95% conﬁdence interval [CI]
1.1e3.2). Target vessel patency rates ranged from 90.5% to
100.0%, while type I/III endoleaks did not exceed 3.0%. The
554 Trans-Atlantic Debatesecond meta-analysis was published the same year by Lin-
sen et al.18 A total of 1622 target vessels perfused by fen-
estrations were analyzed. Technical success, as described by
Chaikoff et al.,13 was 90.4% (95% CI 87.7e92.5). The inci-
dence of type I or III endoleak was 4.6%, and the preser-
vation of target vessels reached 99.0% (1603/1622). Thirty-
day mortality was comparable with what had been previ-
ously reported (2.1%; 95% CI 1.2e3.7).17
Longer-term follow-up is also available for FEVAR. In the
meta-analysis published by Linsen et al.,18 after a follow-up
ranging from 15 to 25 months, all-cause mortality was
16.0% (95% CI 12.5e20.4), among which only six deaths
were considered as aneurysm- or procedure-related. Esti-
mated target vessel patency rate was 93.2% (95% CI 90.4e
95.3) during follow-up.
The durability of branches in fenestrated and branched
endografts was thoroughly assessed by Mastracci et al. on
650 patients,19 although this group contained a mix of JAA
and TAAA repairs. At a mean follow-up of 3 years, only 30
(1.7%) target vessel stent occlusions were reported.
Freedom from branch instability, deﬁned as the absence of
branch occlusion, device migration affecting a branch,
branch-related growth, or need for any secondary inter-
vention was >80.0% at 2 years. KaplaneMeier-estimated
freedom from re-intervention at 5 years was 89.0% (95% CI
78.0e90.0).We recently analyzed renal patency after FEVAR
(376 target renal vessels, mean follow-up of 28.8 months).20
The estimated patency and freedom from re-intervention
rates were 95.0% and 86.7% at 3 years, respectively.Direct comparison
Although there have been no prospective, randomized data
collected, three recent papers have compared Ch-EVAR and
FEVAR. In 2013, Katsargyris et al. published a literature
review comparing early outcomes of F-EVAR (931 patients)
and Ch-EVAR (94 patients) for JAA repairs.21 Primary target
vessel preservation was 98.6% for FEVAR and 98.0% for Ch-
EVAR (nonsigniﬁcant [NS]), and 30-day mortality was 2.4%
versus 5.3% (NS), respectively. Even if not signiﬁcant, there
was a trend towards a higher early mortality in the Ch-EVAR
group, but patients may have been treated in an emergency
setting in this group. This bias was not speciﬁcally investi-
gated. No differences were depicted regarding renal
impairment and new-onset dialysis. Early proximal type I
endoleaks were 4.3% in the FEVAR group and 10.0% in the
Ch-EVAR group (p ¼ .002). No comparisons on mid- and
long-term data were available.
In 2014, Banno et al. reported a monocentric experience
with 80 patients treated with FEVAR and 38 with Ch-
EVAR.22 After a median follow-up of 14 months in the
FEVAR group and 12 months in the Ch-EVAR no differences
were found regarding target vessel event, freedom from re-
intervention, and overall estimated survival. However, the
average number of target vessels in the FEVAR group was
2.4, while it was 1.6 in the Ch-EVAR group (p < .0001). The
proximal extent of the aneurysm was described as higher in
the FEVAR group (p < .001). This supports the fact that theCh-EVAR group was mostly composed of short-neck
infrarenal aneurysms, whereas the FEVAR group had more
true pararenal aneurysms, biasing the analysis. Lee et al.
compared their early experience with FEVAR (n ¼ 15) with
their previous experience with CHIMPS (n ¼ 15).23 In this
study, with a limited follow-up and a small cohort, technical
success and early outcomes were comparable.
TAAA
The sandwich EVAR (SEVAR) technique was initially re-
ported to preserve blood ﬂow in the internal iliac artery in
patients with aneurysms involving the iliac bifurcation.24 It
was then proposed by Lobato and Camacho-Lobato for the
“off-the-shelf” treatment of TAAA.25 Few data are available
on the subject, and results of the two main studies (total of
19 patients) are presented in Table 3.25,26 The largest cohort
included 15 patients,25 with two patients treated emer-
gently. One patient was excluded from the analysis as both
renal arteries could not be cannulated and the procedure
was aborted. Thirty-day mortality rate was 20.0%, and
reached 100.0% in the emergency subset. Among the 54
targeted vessels, ﬁve could not be cannulated (9.2%), and
one more occluded during early follow-up. Technical suc-
cess, according to the reporting standards, was not recor-
ded. Eleven patients were available to follow-up, with a
mean follow-up of 16 months but one was lost after 6
months. Two other patients died of unrelated causes at 10
and 12 months, respectively. One re-intervention was per-
formed for a persistent type II endoleak with sack
enlargement, which was, surprisingly, sealed with an addi-
tional stent between the previous one and the SMA. No
spinal cord ischemia was reported.
On the contrary, early and mid-term outcomes after
TAAA repair with branched EVAR have been reported in
several studies.27e30 Technical success rates ranged from
90.9% to 96.6%, and 30-day mortality from 5.5% to 9.1%. In
our published experience, after the initial learning curve,
spinal cord ischemia occurred in 1.2% of patients (2.1%
when excluding type 4 TAAA), 30-day mortality rate was
5.6% and overall 1-year survival rate was 81.9%.31 These
results conﬁrm the feasibility of such a repair and are
associated with promising early and mid-term outcomes.
DISCUSSION
The literature reporting early and mid-term outcomes for
branch vessel incorporation in aneurysm repair is very
heterogeneous and describes an early experience reﬂective
of the novelty of this technology. It is probably too soon for
such an analysis, but we do not believe that a monitored
prospective randomized study will ever be performed. This
thorough analysis of the literature has raised speciﬁc issues
associated with CHIMPS that need to be emphasized.
First, the gutters created between the main graft and the
chimneys may limit the durability of this technique. As
stated by Schiro et al.,8 aneurysm exclusion is not achieved
with gutters and they are associated with type I endoleaks.
In theory, the more chimneys, the higher the risk of
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the endograft are probably associated with better gutter
thrombosis rates;5 however, this was not demonstrated
in vivo, and length is also correlated with in-stent throm-
botic risk. FEVAR branched stents are generally shorter,
straighter, and in a position more representative of native
anatomy. In contrast, Ch-EVAR has stents that are generally
longer and have a tortuous pathway, often with an acute
bend at the target vessel ostium. A longer and kinked stent
is going to have lower patency in the long term. Long-term
data are not available but these fundamental issues will
probably lead to signiﬁcant differences in patency rates and
translate to the ultimate utility of each technique. Type I
endoleaks are considered the “Achilles’ heel” of CHIMPS. Up
to 10.2% of patients are discharged with type I endoleaks
after CHIMPS repair.14 Schiro et al. report,8 among nine
patients treated with chimneys, two patients with type Ia
endoleaks who died of aneurysm rupture during follow-up,
despite uneventful procedures and early outcomes. There-
fore, it appears that the “Achilles’ heel” of CHIMPS is more
likely a “sword of Damocles”. Reporting standards consider
(low-ﬂow) type I endoleaks a technical failure. How else
should we consider a postoperative perfused aneurysm?
CHIMPS procedures require extensive navigation in the
arch. It is thus associated with an increased incidence of
stroke, as stated by several authors.6,12 In the Ch-EVAR
meta-analysis,12 postoperative stroke rate reached 3.2%,
while it was only 0.3% in the FEVAR meta-analysis per-
formed by Katsargyris et al. (p ¼ .012).21
Ch-EVAR has spread widely in the ﬁeld of PAA and JAA
treatment. The highlighted reasons were that F-EVAR was
too expensive and time-consuming to manufacture, and
thus not an option in emergency cases. However, the
development of manufactured “off-the-shelf” fenestrated
and branched endografts will soon overcome this issue for
most patients.32,33 Moreover, standardization should allow
for a decrease of manufacturing costs. In addition, FEVAR is
now reimbursed in many countries, unlike CHIMPS, which
are considered “off-label” techniques. In an anatomic study
of 206 patients with ruptured aneurysms, Dias et al. re-
ported 33 patients (24.0%) with short necks, of whom 25
(76.0%) were potential candidates for a chimney repair.34
This compares well with the 70.0% suitability of “off-the-
shelf” fenestrated endografts reported in a study evaluating
“nonruptured” juxtarenal aneurysms.32
The argument that CHIMPS are a treatment option for
patients with anatomy unsuitable for FEVAR, in particular in
those with angulated necks, is not supported by speciﬁc
analysis. Currently, most patients deemed unsuitable for
FEVAR are probably unsuitable for any other endovascular
treatment.
Some authors consider Ch-EVAR as an easy procedure
compared with FEVAR, but there is no consensus on this
matter. It is easy to argue that the treatment of a true TAAA
requiring four chimneys is not less challenging than a four-
fenestrated endograft procedure. We believe that it is more
convenient to access four vessels from the contralateral iliac
than it is from the arm where there is much less space for
556 Trans-Atlantic Debatemultiple sheaths. In the experience of Lachat et al.,9 the
mean  SD procedure time, including surgical access and
skin closure, was 248  104 minutes. In comparison, in
2012, our mean procedure time (skin-to-skin) for JAA and
PAA repairs with fenestrated endografts was 150 minutes
(range 40e330 minutes; 54 patients).35 No prospective
randomized trial has or will be performed to compare
operative times between both techniques, but it is clearly
biased to consider FEVAR as technically more challenging
than Ch-EVAR.
In addition, we would also like to emphasize that in the
development of an endovascular graft there are speciﬁc
tests required as deﬁned by international standards.
Worldwide regulatory bodies require compliance to these
standards for approval to sell and market the technology.
When devices are combined together to treat a patient,
evaluation of devices in bench-top testing and clinical
studies are required. In approved therapies this testing has
been completed, and clinical data developed and reviewed
for approval. For approved therapies, such as FEVAR, po-
tential variations in graft and bridging stent conﬁgurations
allowed for in the instructions for use have been thoroughly
evaluated. When one considers the use of endovascular
grafts in combination with bridging stents to perform
CHIMPS, two speciﬁc problems arise: (1) there are nearly an
inﬁnite number of potential graft combinations and
deployment conﬁgurations that need to be evaluated on
the bench top; and (2) there exist little bench-top evidence
that has evaluated potential deployment complications, or
that this is a durable combination in the long term. There
are certainly not any data that have been reviewed by any
regulatory bodies, as no approvals exist anywhere in the
world for CHIMPS.
The literature exhibits solid data regarding feasibility, and
early, mid-, and long-term outcomes after FEVAR. On the
contrary, proof levels regarding Ch-EVAR only allow a
conclusion of its feasibility, especially as mid- and long-term
outcomes have not yet been evaluated. However, the high
rate of type I endoleaks (ranging from 10.0% to 26.0%) after
Ch-EVAR is a major concern, as patients are still exposed to
aneurysm rupture. As stated by Hiramoto et al.,2 Ch-EVAR is
technically demanding and has unpredictable efﬁcacy. It
was ﬁrst described as a bailout technique, and we believe
that this is its only indication. Until manufactured “off-the-
shelf” FEVAR devices become widely available, Ch-EVAR
also has a role in emergency settings.32,33,36REFERENCES
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http://dx.doi.org/10.1016/j.ejvs.2015.07.024Part Two: Against the Motion. Fenestrated EVAR Procedures are not Better
than Snorkels, Chimneys, or Periscopes in the Treatment of Most
Thoracoabdominal and Juxtarenal Aneurysms
Jason T. Lee
Division of Vascular Surgery, Stanford University Medical Center, 300 Pasteur Drive, Suite H3600, Stanford, CA 94305, USAEndovascular aneurysm repair (EVAR) has rapidly overtaken
open surgery worldwide for the treatment of anatomically
suitable aortic aneurysms. It was inevitable that endovas-
cular technology and strategies would be developed to
further treat juxtarenal (JAA) and thoracoabdominal (TAAA)
aneurysms. Centers of excellence and early adopters
outside the USA and US centers with physician-sponsored
investigator device exemptions gained much experience in
using fenestrated and branched (FEN-BR) devices with
excellent results. However, the lack of widespread avail-
ability of branched devices and the only recent US Food andDrug Administration approval of fenestrated technology in
mid-2012 have encouraged an alternative strategy utilizing
parallel, or snorkel, periscope, and chimney grafts (Ch-
EVAR). The snorkel/chimney/periscope technique has
gained increasing popularity since the ﬁrst publications in
2003 and 2007.1,2 These techniques have emerged from the
basic idea of creating a “snorkel/chimney” conduit from
above or a “periscope” conduit from below using available
“off-the-shelf” stents deployed into target visceral branches
adjacent to the main intra-aortic stent-graft. Initially
described as a bail-out technique for inadvertent coverage
